What are the recent financial highlights of INDOCO REMEDIES LTD.?

INDOCO REMEDIES LTD. recently reported a total revenue of ₹1,724.35 Cr and a net profit margin of -0.62%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of INDOCO REMEDIES LTD.?

INDOCO REMEDIES LTD. offers a dividend yield of 0.6%, with a dividend rate of ₹1.5 per share.

What are the key financial metrics of INDOCO REMEDIES LTD.?

Key financial metrics include a trailing P/E ratio of , forward P/E of 17.172003, book value of ₹124.095, price-to-book ratio of 1.8584149, and a market capitalization of ₹21.27 billion.

What does INDOCO REMEDIES LTD. do?

Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infectives, vitamins/minerals/nutrients, ophthal/ontological, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, as well as anti-haemorrhoidal creas and calcium preparations. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company also exports its products. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Indoco

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Indoco

Latest updates related to Indoco

Sr No.	Title	Sentiment
1	Here's why Indoco Remedies shares were under pressure on March 11; details Business Standard	🔄
2	Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility CNBCTV18	🔄
3	Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA Medical Dialogues	🔄
4	#IndocoRemedies' AnaCipher says #USFDA has completed inspection of #Hyderabad facility linkedin	🔄
5	Indoco Remedies gets warning letter from USFDA for Goa plant The Economic Times	🔄
6	Indoco Remedies Faces Significant Volatility Amidst Sustained Downward Trend in Pharmaceuticals Sector MarketsMojo	🔄
7	Indoco Remedies Share Price Today Down 5% Equitymaster	🔄
8	Indoco Remedies partners with Clarity Pharma to launch 20 products in UK market CNBCTV18	🔄
9	Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY Business Standard	🔄
10	Indoco Remedies plunges 8% after warning letter from USFDA for Goa unit Business Standard	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

UTTAMSUGAR AGARWALTUF TPLPLASTEH TGBHOTELS KAYA SHREEPUSHK ORCHASP SAMPANN GENCON SELAN